Few side effects of antipsychotics undermine recovery the way weight gain does. People who feel better mentally on their medication often feel worse about themselves physically — and the metabolic consequences (diabetes, fatty liver, cardiovascular disease) shorten life. The conversation about how to mitigate this has shifted in the last decade. Lifestyle intervention remains essential, but a medication that started life as a diabetes drug — metformin — is now widely recognised as a useful, evidence-supported addition.
Metformin is a generic, well-tolerated diabetes medication that, when added to antipsychotic treatment, modestly limits or reverses antipsychotic-induced weight gain and improves metabolic markers.
The problem metformin addresses
Many antipsychotics cause weight gain — particularly olanzapine, clozapine, quetiapine, and risperidone. The mechanism is complex and includes appetite increase, slowed metabolism, blunted satiety signals, increased food cravings (especially for carbohydrates), and direct effects on insulin sensitivity. Average weight gain in the first year on olanzapine or clozapine often exceeds 10 kg (22 lbs). For background, see antipsychotic weight gain management and metabolic syndrome and antipsychotics.
How metformin works
Metformin's exact mechanism is still debated, even after 60 years of use. The leading theory is that it activates AMP-activated protein kinase (AMPK), which improves insulin sensitivity, reduces hepatic glucose production, and modestly affects appetite. It does not cause hypoglycaemia in non-diabetics, which is one reason it is comfortable to use as a metabolic adjunct.
The evidence
Multiple randomised controlled trials and several meta-analyses (notably Maayan, Vakhrusheva and Correll's 2010 systematic review, and updates since) have shown that metformin added to antipsychotic treatment:
- Reduces weight gain by an average of 3 to 5 kg compared to placebo over several months
- Improves fasting insulin and HOMA-IR (insulin resistance markers)
- Modestly reduces waist circumference
- Reduces the risk of progression to type 2 diabetes
The effect size is modest, not transformative. But for a generic, low-cost, well-tolerated medication, it is one of the better-supported metabolic interventions in psychiatric practice. Both the NICE and APA guidance for schizophrenia mention metformin as an option for managing antipsychotic-induced weight gain.
Typical dosing
Metformin is usually started low to limit gastrointestinal side effects:
- Week 1: 500 mg once daily with food
- Week 2: 500 mg twice daily with food
- Increase as tolerated to 1000 mg twice daily, the typical maintenance target
Some patients tolerate the extended-release form better than the immediate-release form. Effects on weight are usually visible within 8 to 12 weeks if they are going to occur.
Who is it for?
Metformin is most useful when added early — ideally at the same time as a high-weight-gain antipsychotic is started. Adding it after years of weight gain still helps but tends to produce smaller changes. Reasonable candidates include:
- Patients starting clozapine, olanzapine, or quetiapine
- Patients who have gained more than a few kilograms in the first months on any antipsychotic
- Patients with prediabetes, fatty liver disease, or strong family history of diabetes
- Patients with elevated waist circumference, triglycerides, or fasting glucose
Side effects to expect
- Gastrointestinal upset — nausea, diarrhoea, cramping; usually settles over weeks; better with extended-release form and taking with food
- Metallic taste
- Vitamin B12 deficiency — long-term metformin use can lower B12 levels; periodic checking is sensible
- Lactic acidosis — extremely rare but serious; risk is mostly tied to severe kidney impairment, dehydration, alcohol binges, or acute illness
You become severely dehydrated (vomiting, diarrhoea, heat illness), have a major surgical procedure, develop sepsis, or receive intravenous contrast for imaging. Lactic acidosis presents with deep rapid breathing, severe muscle pain, abdominal pain, and confusion.
Special situations
Kidney function
Metformin is cleared by the kidneys. It is not used in advanced kidney disease (eGFR <30) and is dose-reduced between 30 and 45 mL/min/1.73m². Baseline and periodic kidney function testing is standard.
Pregnancy
Metformin has been used extensively in gestational diabetes and PCOS in pregnancy with reassuring data. It is one of the more pregnancy-compatible options for metabolic management.
Alcohol
Heavy or binge drinking on metformin substantially raises the risk of lactic acidosis and should be avoided. Light, infrequent alcohol is generally tolerated.
Where it sits in the bigger picture
Metformin is one piece of a larger puzzle. The most effective approaches to antipsychotic-induced weight gain combine:
- Choosing a lower-weight-gain antipsychotic when clinically reasonable
- Lifestyle intervention — sleep, movement, food quality (see Mediterranean diet and exercise)
- Metformin, particularly when started early
- Periodic metabolic monitoring (waist, glucose, lipids, HbA1c)
- Honest conversation about whether the antipsychotic could be switched
Newer options
The GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide) are increasingly being studied for antipsychotic-induced weight gain and are likely to play a growing role over the next several years. They appear to work, but evidence specific to people with schizophrenia is still emerging, costs are high, and long-term data are limited. Metformin remains the most evidence-based starting point.
Practical questions
- Should we add metformin now or wait to see how my weight changes?
- What is the dose schedule, and what should I do if my stomach reacts badly?
- How will we monitor my kidney function and B12?
- What lifestyle changes will pair well with this?
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.